(lp0
S'Oramed: The Atypical Biotechnology Company With Great Upside Potential Seeking Alpha - Jul 1, 2016 Oramed , the biotech company involved in the research and development of orally deliverable insulin, is a great investment opportunity for investors that are looking for a growing small stock in the biotechnology industry.'
p1
aS'Oramed Pharmaceuticals Inc. MarketWatch - Apr 21, 2011 Oramed Pharmaceuticals Inc. NASDAQ: ORMP. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p2
aS"Here's Where Oramed Fits Into The Diabetes Space Seeking Alpha - Feb 17, 2017 One company that is attempting to do exactly that right now, and that looks to have an attractive pitch, is Oramed Pharmaceuticals Inc. . The company's CEO, Nadav Kidron, featured on CNBC's Squawk Box earlier this week and highlighted&nbsp;..."
p3
aS'Oramed Pharmaceuticals Inc. ORMP  Wall Street Journal - Feb 11, 2013 Oramed Pharmaceuticals Inc. ORMP . search. View All companies. AT CLOSE 3:38 PM EST 03/10/17. $6.03 USD; 0.01 0.17%.'
p4
aS'Does Oramed Pharmaceuticals Pass The Smell Test? Seeking Alpha - May 23, 2014 First off, thank you to the M.D. and Pharma classmates who helped to explain the intricacies of the clinical trial and drug patent process.'
p5
aS"Oramed Pharmaceuticals'  CEO Nadav Kidron Hosts Phase IIb Clinical ... Seeking Alpha - Jul 29, 2016 I encourage you to review the cautionary language about forward-looking statements in today's press release, which can be found on Oramed's website, as well as the Company's filings with the Securities and Exchange Commission including, without&nbsp;..."
p6
aS"Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc.  Market Exclusive - May 23, 2016 In the forward looking element of last week's Market Exclusive biotechnology weekly report, we discussed two companies that were set to report key data during the then week ahead.Early Trials Show an Insulin Pill Can Lower Diabetics' Blood Sugar Levels - ScienceAlert"
p7
aS"Oramed Pharmaceuticals, Inc. To Release Phase IIB Clinical Data ... Market Exclusive - May 17, 2016 On May 5, 2016, Oramed Pharmaceuticals, Inc.  announced it would be reporting data from its phase IIb clinical trial in its lead candidate, ORMD-0801, in approximately two weeks' time."
p8
aS'The Dream Of The Insulin Pill: Oramed Vs. Rivals Seeking Alpha - Feb 6, 2014 Oramed Pharmaceuticals , a tiny Israeli company, listed on the Nasdaq, tripled in value since December, although recently it fell back sharply.'
p9
aS'The Importance Of Being Oral Seeking Alpha - Jun 3, 2014 No wonder companies like Oramed Pharmaceuticals  and Novo Nordisk A/S  get a lot of attention when perfecting oral techniques.'
p10
a.